Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Belani

Showing results (61-70 of 298) with videos related to

Pageof 30
Sort By:
Lung Cancer (Amsterdam, Netherlands)|February 9, 2005
Development of docetaxel in advanced non-small-cell lung cancerChandra P Belani, John Eckardt
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 29, 2009
Novel cytotoxic agentsDaniel Morgensztern, Chandra P Belani
Current Opinion in Oncology|April 1, 1990
Therapy for small cell and non-small cell lung cancerC P Belani, J Aisner
Clinical Lung Cancer|November 24, 2004
Combining targeted agents in lung cancerChandra P Belani, Alex Adjei
Seminars in Thoracic and Cardiovascular Surgery|January 8, 2004
Results of clinical trials for locally advanced and metastatic nonsmall-cell lung cancerSakkaraiappan Ramalingam, Chandra P Belani
Clinical Lung Cancer|April 17, 2004
Smoking cessation and treatment outcomeChandra P Belani, Sakkaraiappan Ramalingam
Seminars in Oncology|March 15, 2002
Meaningful survival in lung cancer patientsSakkaraiappan Ramalingam, Chandra P Belani
Cancer|November 17, 2005
Elderly subgroup analysis of a randomized phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for first-line treatment of advanced nonsmall cell lung carcinoma (TAX 326)Chandra P Belani, Frank Fossella
Lancet (London, England)|January 30, 2010
Maintenance therapy for non-small-cell lung cancerChandra P Belani, Jason Liao
Expert Opinion on Pharmacotherapy|December 11, 2002
Taxanes for advanced non-small cell lung cancerSakkaraiappan Ramalingam, Chandra P Belani
Pageof 30

Showing results (61-70 of 298) with videos related to

Sort By:
Pageof 30
Lung Cancer (Amsterdam, Netherlands)|February 9, 2005
Development of docetaxel in advanced non-small-cell lung cancerChandra P Belani, John Eckardt
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 29, 2009
Novel cytotoxic agentsDaniel Morgensztern, Chandra P Belani
Current Opinion in Oncology|April 1, 1990
Therapy for small cell and non-small cell lung cancerC P Belani, J Aisner
Clinical Lung Cancer|November 24, 2004
Combining targeted agents in lung cancerChandra P Belani, Alex Adjei
Seminars in Thoracic and Cardiovascular Surgery|January 8, 2004
Results of clinical trials for locally advanced and metastatic nonsmall-cell lung cancerSakkaraiappan Ramalingam, Chandra P Belani
Clinical Lung Cancer|April 17, 2004
Smoking cessation and treatment outcomeChandra P Belani, Sakkaraiappan Ramalingam
Seminars in Oncology|March 15, 2002
Meaningful survival in lung cancer patientsSakkaraiappan Ramalingam, Chandra P Belani
Cancer|November 17, 2005
Elderly subgroup analysis of a randomized phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for first-line treatment of advanced nonsmall cell lung carcinoma (TAX 326)Chandra P Belani, Frank Fossella
Lancet (London, England)|January 30, 2010
Maintenance therapy for non-small-cell lung cancerChandra P Belani, Jason Liao
Expert Opinion on Pharmacotherapy|December 11, 2002
Taxanes for advanced non-small cell lung cancerSakkaraiappan Ramalingam, Chandra P Belani
Pageof 30